Click a link below to view the mailing archive as if it had been sent to you.
| 2022-06-30 12:15 | | Big Pharma not Likely to Bail Out Battered Biotech Industry and more... |
| 2022-06-30 00:15 | | After phase 2 flop, Novo Nordisk says its NASH work is 'still very much on track' and more... |
| 2022-06-29 12:15 | | Pharma’s post-pandemic launch performance problem: what’s the prognosis? and more... |
| 2022-06-29 00:15 | | Novartis Reveals Restructure will Cost up to 8,000 Jobs and more... |
| 2022-06-28 12:15 | | Trial failure for Jazz’s cannabis-derived drug blunts goal to expand its use to US and more... |
| 2022-06-28 00:15 | | Small and Medium Biotech Companies Still Growing in Uncertain Times and more... |
| 2022-06-27 12:15 | | Ipsen beefs up in oncology, buying US biopharma Epizyme and more... |
| 2022-06-25 00:15 | | Acquisition in the air? Merck and Seagen to meet this week: WSJ |
| 2022-06-24 12:15 | | Sanofi, GSK tout 72% Omicron efficacy in PhIII trial of next-gen, bivalent shot — with an eye to year-end rollout and more... |
| 2022-06-24 00:15 | | FDA suspends US testing of Sarepta Duchenne drug over safety concerns and more... |
| 2022-06-23 12:15 | | Novartis: FDA OKs Tafinlar + Mekinist For Solid Tumors With BRAF V600E Mutation and more... |
| 2022-06-23 00:15 | | Google Cloud exec: Real-world data could eliminate the need for placebos in clinical trials and more... |
| 2022-06-22 12:15 | | Merck outflanks Pfizer's 20-valent shot with pneumococcal vaccine approval for kids and more... |
| 2022-06-22 00:15 | | Cardiologs is using Holter recordings instead of ECGs to catch more cases of AFib and more... |
| 2022-06-21 12:15 | | Human Longevity makes a move toward Nasdaq with potential SPAC deal, but nothing's final yet and more... |
| 2022-06-21 00:15 | | Pharma industry slams WTO move on TRIPS waiver and more... |
| 2022-06-20 12:15 | | Janssen Recruiting for Phase III Trials of Potential Myasthenia Gravis Game Changer and more... |
| 2022-06-17 12:15 | | Rumor mill says AstraZeneca may be eyeing a takeover of Mereo and more... |
| 2022-06-17 00:15 | | With Positive Data, Checkpoint Looks to Add Second Indication to BLA and more... |
| 2022-06-16 12:15 | | Wipeout: Roche's anti-amyloid attack on presymptomatic Alzheimer's ends in failure and more... |
| 2022-06-16 00:15 | | FDA advisory panel votes unanimously that Pfizer and Moderna shots be authorized for young children and more... |
| 2022-06-15 12:15 | | FDA panel weighs COVID vaccines for children as young as 6 months and more... |
| 2022-06-15 00:15 | | Chasing Sage, PureTech’s oral depression drug clears early bioavailability test and more... |
| 2022-06-14 12:15 | | Biotech edges toward gender parity, but C-suites stay male, white and more... |
| 2022-06-14 00:15 | | A new day for pediatric cancer patients: Day One's share price doubles on initial data for brain tumor drug and more... |
| 2022-06-13 12:15 | | Pfizer, BioNTech's COVID Shot Safe in Young Kids Per FDA and more... |
| 2022-06-13 00:15 | | bluebird bio Soars as FDA Adcom Recommends Second Gene Therapy and more... |
| 2022-06-10 12:15 | | FDA panel backs Bluebird gene therapy despite safety risks and more... |
| 2022-06-09 12:15 | | New GSK debuts with renewed purpose, strategy and brand identity as it says goodbye to consumer business and more... |
| 2022-06-09 00:15 | | AstraZeneca trots out Evusheld data to expand the COVID preventive drug into the treatment arena and more... |
| 2022-06-08 12:15 | | FDA approves Sanofi and Regeneron’s Dupixent for atopic dermatitis in young children and more... |
| 2022-06-08 00:15 | | Novavax on the Verge as FDA Adcom Recommends COVID-19 Vaccine and more... |
| 2022-06-07 12:15 | | Roche keeps the faith in new cancer immunotherapy despite trial setbacks and more... |
| 2022-06-07 00:15 | | ASCO22: New data backs BMS’ investment in Eisai’s first cancer ADC and more... |
| 2022-06-06 12:15 | | ASCO: It's all tied up? Mirati's KRAS data are 'identical' to Amgen's, researcher says and more... |
| 2022-06-06 00:15 | | ASCO: BioNTech's Roche-partnered cancer vaccine combo hints at survival benefit in prostate cancer and more... |
| 2022-06-03 12:15 | | Bristol Myers bets $4B on Turning Point and its targeted cancer drugs and more... |
| 2022-06-03 00:15 | | J&J, BMS arthritis drugs lowered death risk among COVID patients in federal study and more... |
| 2022-06-02 12:15 | | Roche pays Repare $125M to join Big Pharma peers in cancer race and more... |
| 2022-06-02 00:15 | | FDA withdraws cancer drug approval after finding possible higher death rates and more... |
| 2022-06-01 12:15 | | Who needs Humira? AbbVie projected to be the top pharma company by sales in 2028: analysts and more... |
| 2022-06-01 00:15 | | Will third time be the charm? Lexicon finally refiles SGLT2 drug for heart failure and more... |
